(Hypertension. 1996;27:859-866.)
© 1996 American Heart Association, Inc.
Articles |
Phorbol Ester Activation of the Rat Vascular Myocyte Na+-H+ Exchanger Isoform 1
From the Department of Medicine and Therapeutics, Leicester (UK) Royal Infirmary.
Correspondence to Dr Martin Siczkowski, Division of Clinical Pharmacology, Department of Medicine and Therapeutics, Clinical Sciences Building, Leicester Royal Infirmary, Leicester LE2 7LX, UK.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract Vascular myocytes from the spontaneously hypertensive rat (SHR) demonstrate elevated Na+-H+ exchanger activity associated with increased cell proliferation and hyperresponsiveness to agonists such as phorbol esters. Since the Na+-H+ exchanger isoform 1 (NHE-1) is stimulated by protein kinase C, we have investigated the effects of phorbol esters on NHE-1 activity and its phosphorylation in vascular myocytes of these rats. SHR cells demonstrated a larger alkalinization response to 12-O-tetradecanoylphorbol 13-acetate than Wistar-Kyoto rat (WKY) cells. Kinetic analyses indicated that whereas 12-O-tetradecanoylphorbol 13-acetate increased the maximal transport capacity of NHE-1 in both cell types, affinity for H+ was increased in WKY cells and cooperativity for H+ at the internal modifier site was reduced in SHR cells. In neither cell type was the subcellular distribution of NHE-1 altered by phorbol ester stimulation. NHE-1 phosphorylation was markedly reduced in WKY cells stimulated by the phorbol ester, an effect abolished by inhibition of protein kinase C. In contrast, NHE-1 phosphorylation in quiescent SHR cells was approximately double that of WKY cells and was reduced after phorbol ester treatment. Inhibition of protein kinase C in SHR cells led to a marked elevation of NHE-1 phosphorylation that was not associated with a change in exchanger activity, but WKY cells exhibited a small, insignificant rise in NHE-1 phosphorylation. Thus, the kinetic responses of NHE-1 to phorbol esters in vascular myocytes of these rat strains are different, the changes in exchanger kinetics of SHR resembling those described in human hypertension. NHE-1 phosphorylation has an inverse relationship with protein kinase C activity. However, modulation of NHE-1 phosphorylation may not be associated with concurrent alterations in activity, indicating a role for non–phosphorylation-dependent mechanisms.
Key Words: Na+-H+ exchanger • vascular myocytes • phorbol esters • phosphorylation
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
A well-recognized membrane transport abnormality in hypertension is elevation of NHE activity.1 2 This has been demonstrated in skeletal muscle of SHR compared with normotensive WKY in vivo3 and persists despite culture in vitro of striated4 and vascular4 5 6 myocytes. This increased NHE activity of SHR vascular myocytes is associated with an increased cell proliferation rate5 6 that may be due to hyperresponsiveness of these cells to agonists and growth factors.7 8 9 10 The increased NHE activity of SHR vascular myocytes in vitro is associated with an increased Vmax of the exchanger,4 with no change in the pH0.5. This increase in Vmax of the SHR exchanger is not due to an increased expression of NHE isoform 1 (NHE-1) mRNA11 ; the presence of other NHE isoforms such as NHE-2, -3, and -411 ; or increased cellular content of NHE-1 protein.12 NHE-1 is thus the sole isoform present in vascular myocytes, and it is likely that a posttranslational processing mechanism acting on this isoform may be responsible for the increased exchanger activity in SHR cells.
One process that could lead to activation of NHE activity is
phosphorylation.13 14 15 Stimulation of cells
with 
-thrombin, growth factors, okadaic acid, and phorbol esters
causes a dramatic increase in NHE-1 phosphorylation
accompanied by enhancement of exchanger activity. Many agonists
stimulate phosphoinositide hydrolysis to
generate inositol 1,4,5-trisphosphate and diacylglycerol, the latter
messenger then stimulating PKC. The C-terminal of rat NHE-1 possesses a
putative PKC phosphorylation site.16
Furthermore, some previous reports have suggested an increased
contractile response to phorbol esters (which substitute for
diacylglycerol in stimulating PKC) in isolated aortas and renal artery
of SHR,17 18 with increased PKC activity in the soluble
fraction of renal artery.18 Antagonists
of PKC could relax aortic tone in vitro and lower blood pressure
of SHR in vivo.19 These findings have prompted us to
investigate further the mechanism of NHE-1 activation by phorbol esters
in vascular myocytes of SHR compared with WKY and whether differences
in NHE-1 activation between these rat strains could be attributed to
alterations in the degree of NHE-1 phosphorylation. Our
studies demonstrate that the response to phorbol ester stimulation of
NHE-1 in vascular myocytes of both strains involved a substantial
increase in the Vmax of the exchanger. This was
not associated with any significant alteration in the subcellular
distribution of NHE-1 in either cell type. However, stimulation by
phorbol ester was accompanied by an increased affinity for
intracellular H+ in WKY cells (increased
pH0.5), whereas SHR cells demonstrated a reduced
cooperativity for intracellular H+ (lowered Hill
coefficient), perhaps indicating an anomalous interaction with the
intracellular H+ modifier site. These very different
kinetic responses to phorbol esters between the rat strains were
accompanied by a reduction in NHE-1 phosphorylation in
WKY cells (and to a lesser extent in SHR cells), thus dissociating
phorbol ester stimulation of NHE-1 from an increase in its
phosphorylation.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Materials
Dulbecco's modified Eagle's medium (DMEM), Ham's F-12 medium, chick embryo extract, and [32P]orthophosphate were from ICN Flow. Fetal calf serum was from Advanced Protein Products. Ham's F-12 growth medium was buffered with 14 mmol/L NaHCO3 (pH 7.1, with 5% CO2 in air) and contained 15% fetal calf serum, 0.5% (wt/vol) chick embryo extract, 2 mmol/L glutamine, 105 IU penicillin per liter, and 100 mg streptomycin per liter. Protein A–Sepharose-CL4B beads were obtained from Pharmacia LKB Biotechnology. 14C molecular weight markers, the enhanced chemiluminescence kit, and Aurodye were purchased from Amersham International. 2',7'-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) was from Cambridge Bioscience. All other chemicals, including TPA, H-7, and Percoll, were from Sigma Chemical Co. The specific PKC inhibitor Ro 318220,20 which inhibits both the calcium-sensitive and -insensitive atypical isoforms of PKC, was obtained from Dr J. Lawton, Roche Products Ltd.
Culture of Vascular Myocytes and Measurement of NHE
Activity
WKY and SHR were maintained at a colony established at the
Biomedical Services Unit, Leicester University. Blood pressures of
12-week-old rats by the tail-cuff method confirmed values in
SHR exceeding 170 mm Hg, with values less than 120 mm Hg in WKY.
Vascular myocytes were obtained from thoracic aortas by enzymatic
dissociation as previously described4 and maintained in
Ham's F-12 growth medium. Studies were performed on cultures between
passages 3 and 8 because previous work suggested that NHE abnormalities
were found predominantly in early-passage SHR
cells.5 6 NHE activity was measured in SHR and WKY
confluent vascular myocytes seeded onto glass coverslips as described
previously.4 12 Cells were rendered quiescent by
serum deprivation for 24 hours in DMEM containing 1 g/L
bovine serum albumin, 2 mmol/L glutamine, and antibiotics.
After loading with 5 µmol/L BCECF-AM for 0.5 hour in serum-free
DMEM at 37°C and deesterification for a further 0.5 hour,
pHi was measured after incubation of coverslips in HBSS
composed of (mmol/L) NaCl 130, KCl 5, CaCl2 1.8,
MgSO4 1, glucose 5, and HEPES 20 as well as 1 g/L bovine
serum albumin, pH 7.4. All measurements were performed at
37°C with a thermostatted sample compartment holder within a dual
grating fluorometer (Deltascan, Photon Technology International Inc).
NHE activity was determined at a range of different pHi
from 6.0 to 7.2 after clamping of pHi with nigericin and
monensin (5 µmol/L of each) in isotonic KCl buffers (replacing the
NaCl of HBSS with KCl and omitting the bovine serum albumin) by
measuring the difference between the total rate of change of
pHi and that measured in Na+-free medium
(replacing the NaCl in HBSS with
N-methyl-D-glucamine chloride, pH 7.4),
as described.4 Values of Na+-dependent rate of
pHi change were converted to efflux rates by multiplying
them by the buffering capacities measured at these various clamped
pHi values. Measurements were then repeated on cells that
had been preincubated with 100 nmol/L TPA in HBSS at 37°C. Studies
with Ro 318220 were performed by incubation of cells with 10 µmol/L
of the inhibitor for 20 minutes at 37°C and then
measurement of pHi and NHE activity or by addition of 100
nmol/L TPA after preincubation with the inhibitor. These
studies were repeated with another PKC inhibitor, H-7 (50
µmol/L). An additional technique of downregulating PKC by prolonged
(24 hours) incubation of cells in 100 nmol/L TPA was also used, and
fluxes were then investigated in cells that were subsequently
stimulated with 100 nmol/L TPA.
NHE fluxes were fitted to the logistic (Hill) equation to obtain values for Vmax, pH0.5, and the apparent Hill coefficient for the internal H+ binding site of the antiport. The computer program used to derive these parameters was a recursive nonlinear least-squares algorithm (P-fit, Biosoft Corp). These parameters were also checked with another nonlinear optimization algorithm that we have used previously21 and that uses the pattern search method to minimize the sum of errors squared between calculated and observed NHE flux values. Both algorithms produced very similar results for the different parameters Vmax, pH0.5, and the Hill coefficient.
Determination of NHE-1 Abundance by Western Blotting
We have previously described the use of NHE-1–specific
polyclonal antibodies to the last 157 amino acids of the regulatory
C-terminal of NHE-1 for detection of NHE-1 protein in vascular
myocytes.12 22 G252 and G253 are protein A
Sepharose–purified immunoglobulin fractions from these
antisera.
We measured NHE-1 abundance in cultures from SHR and WKY myocytes by Western blots of these cell extracts using a previously described method employing G252 antibody.12 22 This ensured that the subsequent phosphorylation studies used similar numbers of NHE-1 transporters in the two different strains. Serum-deprived (24 hours) quiescent cultures were studied before and after 20 minutes of stimulation with 100 nmol/L TPA at 37°C. Briefly, after cells were snap-frozen with liquid nitrogen, they were scraped off the tissue culture flasks into a buffer containing (mmol/L) Tris 50 (pH 7.4), NaCl 140, EDTA 5, phenylmethylsulfonyl fluoride 1, o-phenanthroline 1, and iodoacetamide 1. An equal volume of buffer containing 125 mmol/L Tris (pH 6.8), 4% sodium dodecyl sulfate, 20% glycerol, and 0.004% bromophenol blue was added, and the extracts were boiled for 3 minutes. Proteins were resolved on 7.5% SDS-PAGE gels followed by electrotransfer onto supported nitrocellulose. Membranes were blocked overnight with 10% low-fat milk powder in TBS-Tween (composed of 20 mmol/L Tris [pH 7.4], 137 mmol/L NaCl, and 1 g/L Tween 20). The first antibody incubation was with 1 µg/mL of G252 antibody in 5% low-fat milk powder in TBS-Tween for 2.5 hours. After extensive washes in TBS-Tween, horseradish peroxidase–linked donkey anti-rabbit second antibody (1:1500 dilution) was incubated with the membranes for 1 hour. Detection was achieved with the enhanced chemiluminescence kit from Amersham. The bands corresponding to NHE-1 (molecular weight around 95 kD) were measured on a Bio-Rad densitometer.12 22
Subcellular Fractionation of Vascular Myocyte
Homogenates
For investigation of whether there was any intracellular
compartmentalization of NHE-1 or an alteration of this subcellular
distribution after 20 minutes of stimulation with 100 nmol/L TPA at
37°C, monolayers of SHR or WKY myocytes were detached from flasks
with EDTA after two brief washes in HBSS.21 22 Cells were
then disrupted by nitrogen cavitation in 3 mL of
homogenization buffer composed of 250 mmol/L
sucrose, 1 mmol/L EDTA, and 1 mmol/L phenylmethylsulfonyl
fluoride, pH 7.2, as described.21 22 After a
10-minute centrifugation (600g), the
postnuclear supernatant was layered onto a self-generated 30%
Percoll gradient preformed on an ultracentrifuge at
27 000g for 60 minutes at 4°C. Membranes and cellular
organelles were recovered at the following densities (in grams per
milliliter, as indicated by beads): 1.042, 1.05, 1.056, 1.069 to 1.083,
and 1.102 to 1.128. Proteins were determined by the fluorescamine
method,21 22 and 7.5% SDS-PAGE gels were then loaded with
equal amounts of protein per track. Western blots were performed as
described above. Enzyme markers were used for determination of the
location of membrane and organelle fractions as
described.21 22 The plasma membrane marker 5'-nucleotidase
(EC 3.1.3.5) was enriched in the fraction with a density of 1.042 g/mL
in all extracts.
Determination of NHE-1
Phosphorylation
In the present studies, G253 was used for
immunoprecipitation of labeled NHE-1, which is visualized as a 95-kD
phosphoprotein in rat vascular myocyte extracts, as illustrated
previously.23 Nonspecific immunoglobulin did not
immunoprecipitate any labeled protein in this region (data not shown).
The method for immunoprecipitation of NHE-123 was adapted
from that of Sardet et al.13 Quiescent vascular myocyte
cultures were loaded with [32P]orthophosphate (50
µCi/mL) for 3 hours in phosphate-free HBSS composed of (mmol/L)
NaCl 130, KCl 5, CaCl2 1.8, MgSO4 1, glucose 5,
HEPES 20, and glutamine 2 as well as 1 g/L bovine serum
albumin, pH 7.4. After brief washes with cold HBSS, cells were
snap-frozen with liquid nitrogen. One milliliter of cold (4°C)
extraction buffer containing 10 g/L polyoxyethylene-8-lauryl ether and
(mmol/L) Tris 30, NaCl 130, EDTA 5, phenylmethylsulfonyl
fluoride 1, o-phenanthroline 1, iodoacetamide
1, sodium fluoride 100, sodium orthovanadate 5, ATP 10, and
sodium pyrophosphate 10 as well as 1 mg/L pepstatin A and 2 mg/L
leupeptin was then added to the frozen cells, and the monolayers were
scraped off the plastic flasks. Extracts were sonicated and then
clarified by centrifugation at 14 000g. The
supernatant was preabsorbed with protein A–Sepharose-CL4B beads
followed by centrifugation. The antibody G253 was then
added to the supernatant (final concentration, 100 µg/mL), and the
samples were rotated end on end for 2 hours at 4°C.
Immunoprecipitates were recovered after a 1-hour incubation with
protein A–Sepharose-CL4B beads (previously treated with unlabeled
vascular myocyte cell extracts to reduce nonspecific binding). After
the beads had been washed extensively, Laemmli sample buffer was added
and extracts were boiled. Phosphoproteins were resolved on 7.5%
SDS-PAGE gels and quantified by autoradiography on
preflashed x-ray films.23 All values have been
normalized to an arbitrary value of 1 for the quiescent WKY cell
extract. With these techniques, our preliminary studies had indicated
that SHR myocytes showed a larger increment in pHi and
NHE-1 phosphorylation than WKY myocytes when stimulated
with 100 nmol/L arginine vasopressin for 20 minutes (results not
shown).
We investigated the effect of TPA on NHE-1 phosphorylation by incubating quiescent 32P-labeled myocyte cultures in HBSS containing 100 nmol/L TPA for 20 minutes at 37°C and then snap-freezing the monolayer with liquid nitrogen. Incubations with 10 µmol/L Ro 318220 were performed for 40 minutes at 37°C followed by snap-freezing. Alternatively, 100 nmol/L TPA was added to cells preincubated with Ro 318220 for 20 minutes, and after a further 20 minutes, the reaction was terminated by freezing with liquid nitrogen. We determined the effect of H-7 by incubating cells for 20 minutes at 37°C with the inhibitor (50 µmol/L) and then snap-freezing the cells. Downregulation of PKC was also achieved by incubation of cells for 24 hours with 100 nmol/L TPA (the last 3 hours of the incubation was performed in phosphate-free HBSS containing [32P]orthophosphate).
Statistics
Results are expressed as mean±SE, and comparisons were made by
ANOVA and Student's t test, performed on an Oxstat
statistics package (Microsoft Corp). Two-tailed probability values
less than .05 were considered significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Fig 1
shows the effect of 100 nmol/L TPA on the
pHi of serum-deprived SHR and WKY vascular myocytes.
TPA led to significant alkalinization in both cell types, a peak effect
being achieved between 10 and 20 minutes. Although the pHi
at rest was higher in SHR than WKY myocytes (P<.05), the
difference became more marked after stimulation with TPA
(P<.005 at 20 minutes after TPA). In the presence of 100
nmol/L ethylisopropyl amiloride, no increase in pHi was
demonstrable, indicating that NHE-1 was stimulated by TPA (data not
shown). All subsequent experiments were therefore performed on cells
after stimulation with TPA for 20 minutes.
|
Intracellular pH and NHE activity at pHi 6.0 were measured
in both cell types before and after stimulation with TPA as well as in
the absence and presence of the PKC inhibitors Ro 318220
and H-7. ANOVA revealed very significant differences between the
quiescent and TPA-stimulated cells in the absence and presence of Ro
318220 and H-7 for both intracellular pH and NHE activity measurements
(P<.005 for both parameters in WKY and SHR
cells). The NHE activity of SHR cells was significantly higher than
that in WKY cells before stimulation (P<.001, Fig 2). On stimulation with TPA, NHE activity was increased
in both cell types (P<.001). The NHE activity of SHR cells
after TPA stimulation remained significantly elevated compared with
that in WKY cells (P<.001, Fig 2). The PKC
inhibitor Ro 318220 was incubated with these cells for
assessment of the dependence of unstimulated NHE activity and
pHi on PKC. Ro 318220 had no effect on either
pHi or NHE activity of both WKY and SHR cells, suggesting
that neither parameter depended on PKC activity. However,
this inhibitor abolished the TPA-induced alkalinization and
increase in NHE activity of both cell types (Fig 2), thus indicating
that PKC may be involved in the TPA stimulation of NHE activity in both
cell types. We confirmed this effect of Ro 318220 by incubating cells
with another PKC inhibitor (H-7) and also by downregulating
PKC with prolonged 24-hour exposure to 100 nmol/L TPA. Both maneuvers
did not alter pHi or NHE activity of the WKY and SHR cells
but did abolish the subsequent stimulation by 20-minute incubations
with TPA (Fig 2).
|
We examined the kinetics of NHE activity in greater detail by clamping
pHi to different levels between 6 and 7.2 and investigating
the Na+-dependent H+ efflux in both cell types
before and after TPA stimulation. It was not possible to clamp
pHi below 6.0 because the dye BCECF is not very sensitive
to changes in pH below this value. In unstimulated cells, the
Vmax of SHR cells was significantly increased
compared with that in WKY cells (P<.001), with similar
values for the Hill coefficient, although SHR cells also exhibited an
increased affinity for intracellular H+ (an increased
pH0.5, P<.005, Fig 3 and
Table). The increased
Vmax in quiescent SHR cells confirms our
previous report,4 although in those serum-stimulated
cells4 we could not demonstrate any differences in the
Hill coefficient or pH0.5. Incubation with TPA led to very
significant increases in the Vmax of NHE-1 in
both WKY and SHR cells (Fig 3 and Table, P<.001 for both
strains). However, in addition, TPA-stimulated WKY cells demonstrated
an increased affinity for intracellular H+ (a rise in
pH0.5, P<.001), with no change in the
Hill coefficient. In contrast, when stimulated with TPA, SHR cells
showed no change in the affinity for intracellular H+ but
rather a reduced Hill coefficient (P<.01), indicating a
reduced cooperativity of H+ at the internal modifier site
of NHE-1. Thus, after stimulation with TPA, the
Vmax in SHR cells was higher
(P<.001), with a lowered Hill coefficient
(P<.01) and lower pH0.5 (P<.001)
than these parameters in WKY cells.
|
|
The similar abundance of NHE-1 in SHR and WKY vascular myocytes has
previously been described.12 In the current investigation,
Western blots with the NHE-1–specific antibody G252 revealed that the
ratio of NHE-1 protein in SHR and WKY vascular myocyte extracts was
0.99±0.11 (n=3). Incubation with 100 nmol/L TPA for 20 minutes did not
significantly alter the amount of NHE-1 extracted from the WKY cell
cultures using the buffer containing polyoxyethylene-8-lauryl ether
(Fig 4). The ratio of NHE-1 densities after TPA and in
quiescent WKY cells was 1.01±0.11 (n=3). In contrast, the ratio of
NHE-1 densities in extracts after 20 minutes of TPA stimulation and in
quiescent SHR cells was 0.80±0.11 (n=3), indicating a slight reduction
in extractable NHE-1 from SHR myocytes (Fig 4). Thus, the stimulation
of NHE-1 activity measured fluorometrically was not accompanied by any
increase in extractable NHE-1 in either cell type.
|
Because of the increased Vmax of both cell types stimulated by TPA, we examined whether this phenomenon could be attributed to an altered subcellular localization of NHE-1. Using isopycnic centrifugation through a Percoll gradient,22 we found that the NHE-1 of quiescent SHR and WKY cells was predominantly located in the plasma membrane fraction in three separate experiments (as indicated by the location of the marker enzyme 5'-nucleotidase at a density of 1.042 g/mL, which was enriched by 3.2- to 3.8-fold compared with the postnuclear supernatant). In this fraction, immunoreactive NHE-1 was enriched approximately 2.2- to 2.4-fold in extracts of both cell types compared with the postnuclear supernatant. After 20 minutes of TPA stimulation, the subcellular distribution of NHE-1 did not change, the majority of the exchanger being recovered in the plasma membrane fraction (in which NHE-1 was enriched 2.1- to 2.2-fold compared with the postnuclear supernatant). Thus, the increase in Vmax with TPA stimulation of both cell types was not associated with any redistribution of NHE-1 from an intracellular compartment to the cell surface.
Since phosphorylation of NHE-1 may be one mechanism
leading to its activation,13 14 15 we examined this
posttranslational event in SHR and WKY vascular myocytes stimulated
with TPA. In unstimulated cells, we had previously shown that NHE-1
phosphorylation in SHR cells was approximately double
that of WKY cells23 although the NHE-1 protein content was
very similar between strains.12 All NHE-1
phosphorylation results reported here have been
corrected to an arbitrary value of 1 in the quiescent WKY
cultures. When WKY vascular myocytes were stimulated with TPA,
NHE-1 phosphorylation was significantly reduced, as
detected by densitometric traces of the region around 95 kD of the
autoradiographs (Table
). ANOVA revealed significant differences between
the quiescent and TPA-stimulated cells and the effect of Ro 318220
incubation with and without TPA (P<.05 by ANOVA in WKY
cells). In six experiments, the NHE-1 phosphorylation
in TPA-stimulated cells fell significantly compared with that in
quiescent WKY cells (Table, P<.001). Incubation of WKY
cells with the PKC inhibitors Ro 318220 and H-7 or
downregulation of PKC with prolonged TPA treatment (24 hours) did not
significantly alter NHE-1 phosphorylation (Table). In
the presence of Ro 318220, TPA did not significantly lower NHE-1
phosphorylation (Table).
In contrast, the NHE-1 phosphorylation of SHR cells
exhibited a different response to TPA stimulation. Significant
differences between SHR cells before and after TPA stimulation in the
presence and absence of Ro 318220 or H-7 were revealed by ANOVA
(P<.005). The NHE-1 phosphorylation in
quiescent SHR cells was elevated compared with that in quiescent WKY
cells (Table, P<.001). NHE-1
phosphorylation was reduced by TPA stimulation in SHR
cells (P<.03), but this reduction was to a level of about
70% of the NHE-1 phosphorylation values in quiescent
SHR cells. This reduction was significantly different from the response
in WKY cells (P<.02), in which TPA reduced NHE-1
phosphorylation to about 33% of values in untreated
WKY cells. However, the PKC inhibitors Ro 318220 and H-7
led to a substantial increase in NHE-1 phosphorylation
in SHR cells (Table, P<.002 compared with quiescent SHR
cultures), even though there were no associated changes in NHE activity
and pHi. Coincubation of SHR cells with TPA and Ro 318220
led to intermediate levels of NHE-1 phosphorylation.
Prolonged incubation with TPA to downregulate PKC activity had no
effect on NHE-1 phosphorylation, but this procedure may
not have achieved complete downregulation of all the PKC isoforms.
This response to Ro 318220 in SHR cells appeared to be unique to this hypertensive model because lymphoblasts derived from patients with hypertension24 in whom we had shown an increased NHE-1 phosphorylation compared with normotensive subjects do not demonstrate an enhancement of NHE-1 phosphorylation on incubation with Ro 318220 (10 µmol/L of the inhibitor for 40 minutes at 37°C, data not shown).
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
SHR vascular myocytes cultured in vitro exhibit a number of differences compared with WKY cells. These include an increased proliferation rate5 6 7 and altered responsiveness to growth factors and vascular agonists.5 8 9 10 The generation of diacylglycerol as a second messenger during stimulation leads to activation of PKC, and increased responsiveness of SHR aortas to phorbol esters has been demonstrated.17 18 19 Previous findings of increased NHE activity have been associated with the increased proliferation rate of SHR vascular myocytes.5 6
In the present study, we have confirmed the findings of others5 6 and ourselves4 that NHE activity is elevated in unstimulated SHR vascular myocytes compared with WKY cells and that this was mainly attributed to an increased Vmax of NHE-1. However, in our previous study on SHR vascular myocytes that had not been serum deprived,4 we did not observe any differences in the Hill coefficient or pH0.5 of NHE-1. In contrast, the present study on serum-withdrawn quiescent cells demonstrated a higher value for the pH0.5 of NHE-1 in SHR cells (indicating a higher H+ affinity) than WKY cells. Nevertheless, the elevated Vmax of SHR cells compared with that of WKY cells is present in both quiescent and serum-fed cells.
TPA incubation led to a more substantial alkalinization in SHR cells, which confirmed findings in a previous study.10 TPA also led to an increase in Vmax of both cell types that was not due to an increased cellular NHE-1 protein content. This increased Vmax was also not associated with any redistribution of NHE-1 from intracellular compartments to the cell surface. The effect of TPA on NHE activity has previously been documented to be solely an effect on altered pH0.5 of NHE25 rather than on Vmax, but this may be due to cell-specific differences in response. Furthermore, in some cell types, TPA has been reported either to have no effect on NHE-1 activity or to suppress the Vmax in addition to lowering the Hill coefficient.26 Thus, the response of NHE-1 to TPA may depend on the intracellular milieu in which the exchanger is expressed, different kinetic responses being reported in different cell types. In the WKY cells, we have demonstrated that the pH0.5 was increased by TPA, indicating an increased affinity for intracellular H+ resembling the previously reported effect of TPA.25 This contrasts with the effect of TPA on SHR cells, in which no change in affinity for intracellular H+ was demonstrated and stimulation was associated with a fall in the cooperativity of H+ acting at the internal proton modifier site of NHE-1.27 This accounts for the less sigmoidal activation curve of NHE-1 in TPA-stimulated SHR cells, so that activity falls more gradually as pH increases. Thus, in the stimulated SHR cells, pHi could rise further before NHE activity is switched off, explaining the greater alkalinization response of these cells. It is uncertain whether this accounts for a proportion of the increased cell proliferation rate and the hyperresponsiveness to different growth factors and agonists reported in SHR vascular myocytes.5 6 7 8 9 10 Parallels can be drawn between our study and that of Rosskopf et al,28 who have studied the kinetics of NHE-1 in TPA-stimulated lymphoblasts from hypertensive humans. They demonstrated that these TPA-stimulated hypertensive cells showed a lower Hill coefficient for intracellular H+ and an increased Vmax, findings very similar to those we have presented for TPA-stimulated SHR vascular myocytes. In addition, pH0.5 for intracellular H+ was lower in the hypertensive compared with normotensive lymphoblasts, identical to the comparison of TPA-stimulated SHR and WKY cells. Thus, these similarities between studies on humans and the rat model suggest that TPA stimulation of NHE-1 is fundamentally different in cells from hypertensive compared with normotensive individuals.
We have attempted to examine the effect of TPA stimulation of these cells on one mechanism previously described to be associated with NHE-1 activation, ie, NHE-1 phosphorylation.13 14 15 We had previously suggested that the increased NHE activity in SHR vascular myocytes may be associated with the increased phosphorylation of NHE-1.23 However, stimulation of SHR cells with TPA was not associated with a further increase in phosphorylation but a small decrease in NHE-1 phosphorylation of about 30%. In contrast, stimulation of WKY cells actually led to a greater dephosphorylation of NHE-1 of more than 67%. These findings, taken together with the kinetic changes of NHE activity after TPA stimulation, illustrate the very different responses that SHR and WKY cells exhibit, although it is uncertain to what extent dephosphorylation of NHE-1 contributes to the changes in the Hill coefficient or pH0.5 induced by TPA in these cells. In addition, our results contrast with those reported earlier13 in which phorbol esters were reported to enhance NHE-1 phosphorylation. It is possible that the cell lines used for these experiments possess a different balance in the signaling mechanisms leading to NHE-1 activation compared with our primary cultures of vascular myocytes, since these continuous lines also overexpress growth factor (tyrosine kinase–linked) receptors.13 Moreover, other researchers have demonstrated that the NHE-1 activity of HL60 cells was stimulated with phorbol esters and that this led to dephosphorylation of NHE-1.29 Furthermore, several reports have suggested that activation of NHE-1 may not be associated with its phosphorylation. For example, the increase in NHE activity with an osmotic stimulus is not associated with an increased phosphorylation.30 Deletion mutants of NHE-1 revealed that stimulation of the exchanger without an increased phosphorylation was still possible when sections of the regulatory C-terminal domain were removed, although the response to growth factors was halved,31 suggesting that other regulatory proteins may interact with and activate NHE-1.31 32 Thus, one possibility for the differences in the response of SHR and WKY cells to TPA may be an altered interaction between such regulatory proteins and NHE-1 that is phosphorylated to varying degrees in these cells.
Inhibition of PKC in the present studies led to no significant changes in NHE activity or pHi in either the WKY or SHR cells, although the effect of TPA on stimulating NHE-1 activity was abolished. Furthermore, downregulation of PKC with prolonged TPA incubation led to no significant changes in NHE activity. This meant that the NHE activity of quiescent vascular myocytes was PKC independent, as was the difference in NHE activity between quiescent SHR and WKY cells. The relationship of NHE-1 phosphorylation to PKC activity was also documented to be inverse rather than direct (as demonstrated by TPA-induced dephosphorylation of NHE-1, especially in WKY cells, and the elevation of NHE-1 phosphorylation by PKC inhibitors, especially in SHR cells). This concurred with the data reported for HL60 cells29 as opposed to ER22 fibroblasts13 and presents further evidence that non–phosphorylation-dependent mechanisms exist for the PKC-mediated activation of NHE-1.30 31 32
In summary, we have demonstrated that the kinetics of NHE-1 in SHR and WKY cells differ in the quiescent state and this is manifested as an increased Vmax and increased pH0.5 in SHR cells. TPA led to increases in Vmax in both cell types but to an increased internal H+ affinity in WKY cells and a reduced cooperativity at the internal H+ modifier site of NHE-1 in SHR cells. These changes in Vmax were not associated with any alteration in the subcellular localization of NHE-1 in both cell types. The kinetics differences between SHR and WKY cells resemble those described for TPA-stimulated cells from hypertensive and normotensive humans. The combined effect of increased Vmax and reduced cooperativity for H+ at the internal modifier site of NHE-1 in SHR cells may account for the greater alkalinization response of these cells. NHE-1 phosphorylation was increased in SHR compared with WKY cells in the quiescent state, and studies with TPA and PKC inhibitors indicate an inverse relationship between PKC activity and NHE-1 phosphorylation and an upregulated NHE-1 phosphorylation mechanism in SHR cells. Non–phosphorylation-dependent mechanisms may be involved in the TPA-induced stimulation of NHE-1, a possibility being the interaction of putative regulatory proteins with the C-terminal control region of NHE-1 (although the degree of this interaction may be altered by NHE-1 phosphorylation). These possibilities remain to be explored in this rat model of hypertension.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This research was supported by the British Heart Foundation and the Wellcome Trust.
Received May 22, 1995; first decision July 6, 1995; accepted January 3, 1996.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Huot SJ, Aronson PS. Na+-H+ exchanger and its role in essential hypertension and diabetes mellitus. Diabetes Care. 1991;14:521-535. [Abstract]
2.
Rosskopf D, Dusing R, Siffert W. Membrane
sodium-proton exchange and primary hypertension.
Hypertension. 1993;21:607-617.
3. Syme PD, Arnolda L, Green Y, Aronson JKA, Grahame-Smith DG, Radda GK. Evidence for increased in-vivo Na+/H+ antiporter activity and an altered skeletal muscle contractile response in the spontaneously hypertensive rat. J Hypertens. 1990;8:1027-1036. [Medline] [Order article via Infotrieve]
4. Davies JE, Ng LL, Ameen M, Syme PD, Aronson JK. Evidence for altered Na+/H+ antiport activity in cultured skeletal muscle cells and vascular smooth muscle cells from the spontaneously hypertensive rat. Clin Sci. 1991;80:509-516. [Medline] [Order article via Infotrieve]
5. Berk BC, Vallega G, Muslin AJ, Gordon HM, Canessa M, Alexander RW. Spontaneously hypertensive rat vascular smooth muscle cells in culture exhibit increased growth and Na-H exchange. J Clin Invest. 1989;83:822-829.
6. LaPointe MS, Ye M-H, Moe OW, Alpern RJ, Battle DC. Na+/H+ antiporter (NHE-1 isoform) in cultured vascular smooth muscle from the spontaneously hypertensive rat. Kidney Int. 1995;47:78-87. [Medline] [Order article via Infotrieve]
7. Yamori Y, Igawa T, Tagami M, Kanbe T, Nara Y, Kihara M, Horie R. Humoral trophic influences on cardiovascular structural changes in hypertension. Hypertension. 1984;6(suppl III):III-27-III-32.
8.
Scott-Burden T, Resink TJ, Baur U, Burgin M, Buhler
FR. Epidermal growth factor responsiveness in smooth muscle
cells from hypertensive and normotensive rats.
Hypertension. 1989;13:295-304.
9. Scott-Burden T, Resink TJ, Buhler FR. Enhanced growth and growth factor responsiveness of vascular smooth muscle cells from hypertensive rats. J Cardiovasc Pharmacol. 1989;14(suppl 6):S16-S21.
10.
Resink TJ, Scott-Burden T, Baur U, Burgin M, Buhler
FR. Enhanced responsiveness to angiotensin II in
vascular smooth muscle cells from spontaneously hypertensive rats is
not associated with alterations in protein kinase C.
Hypertension. 1989;14:293-303.
11.
Lucchesi PA, DeRoux N, Berk BC.
Na+-H+ exchanger expression in vascular smooth
muscle of spontaneously hypertensive and Wistar-Kyoto rats.
Hypertension. 1994;24:734-738.
12. Siczkowski M, Davies JE, Ng LL. Na+/H+ antiporter protein in normal Wistar-Kyoto and spontaneously hypertensive rat. J Hypertens. 1994;12:775-781. [Medline] [Order article via Infotrieve]
13.
Sardet C, Counillon L, Franchi A, Pouyssegur J.
Growth factors induce phosphorylation of the
Na+/H+ antiporter, a
glycoprotein of 110 kD. Science. 1990;247:723-726.
14.
Sardet C, Fafournoux P, Pouyssegur J.
-Thrombin, epidermal growth factor, and okadaic acid
activate the Na+/H+ exchanger,
NHE-1, by phosphorylating a set of common sites. J
Biol Chem. 1991;266:19166-19171.
15.
Bianchini L, Woodside M, Sardet C, Pouyssegur J, Takai
A, Grinstein S. Okadaic acid, a phosphatase
inhibitor, induces activation and
phosphorylation of the
Na+/H+ antiport. J
Biol Chem. 1991;266:15406-15413.
16.
Orlowski J, Kandasamy RA, Shull GE. Molecular
cloning of putative members of the Na/H exchanger gene family.
J Biol Chem. 1992;267:9331-9339.
17. Bruschi G, Bruschi ME, Capelli P, Regolisti G, Borghetti A. Increased sensitivity to protein kinase C activation in aortas of spontaneously hypertensive rats. J Hypertens. 1988;6(suppl 4):S248-S251.
18. Silver PJ, Lepore RE, Cumiskey WR, Kiefer D, Harris AL. Protein kinase C activity and reactivity to phorbol ester in vascular smooth muscle from spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto rats (WKY). Biochem Biophys Res Commun. 1988;154:272-277. [Medline] [Order article via Infotrieve]
19.
Buchholz RA, Dundore RL, Cumiskey WR, Harris AL, Silver
PJ. Protein kinase inhibitors and blood pressure
control in spontaneously hypertensive rats.
Hypertension. 1991;17:91-100.
20. Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE. Potent selective inhibitors of protein kinase C. FEBS Lett. 1989;259:61-63. [Medline] [Order article via Infotrieve]
21. Ng LL, Davies JE, Siczkowski M, Sweeney FP, Quinn PA, Krolewski B, Krolewski AS. Abnormal Na+/H+ antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J Clin Invest. 1994;93:2750-2757.
22.
Siczkowski M, Davies JE, Ng LL. Activity and
density of the Na+/H+ antiporter in
normal and transformed human lymphocytes and fibroblasts.
Am J Physiol. 1994;267:C745-C752.
23.
Siczkowski M, Davies JE, Ng LL.
Na+/H+ exchanger isoform 1
phosphorylation in normal Wistar-Kyoto and
spontaneously hypertensive rats. Circ Res. 1995;76:825-831.
24.
Ng LL, Sweeney FP, Siczkowski M, Davies JE, Quinn PA,
Krolewski B, Krolewski AS. Na+/H+
antiporter phenotype, abundance and
phosphorylation of immortalized lymphoblasts from
humans with hypertension. Hypertension. 1995;25:971-977.
25.
Vigne P, Frelin C, Lazdunski M. The
Na+/H+ antiport is activated by
serum and phorbol esters in proliferating myoblasts but not in
differentiated myotubes. J Biol Chem. 1985;260:8008-8013.
26.
Takaichi K, Balkovetz DF, Van Meir E, Warnock
DG. Cytosolic pH sensitivity of an expressed human NHE-1
Na+-H+ exchanger. Am J
Physiol. 1993;264:C944-C950.
27. Aronson PS, Nee J, Suhm NA. Modifier role of internal H+ inactivating the Na+/H+ exchange in renal microvillus membrane vesicles. Nature. 1982;299:161-163. [Medline] [Order article via Infotrieve]
28. Rosskopf D, Fromter E, Siffert W. Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients: a cell culture model for human hypertension. J Clin Invest. 1993;92:2553-2559.
29.
Rao GN, Sardet C, Pouyssegur J, Berk BC.
Phosphorylation of Na+-H+
antiporter is not stimulated by phorbol ester and acidification in
granulocytic HL-60 cells. Am J Physiol. 1993;264:C1278-C1284.
30.
Grinstein S, Woodside M, Sardet C, Pouyssegur J, Rotin
D. Activation of the Na+/H+
antiporter during cell volume regulation. J
Biol Chem. 1992;267:23823-23828.
31.
Wakabayashi S, Bertrand B, Shigekawa M,
Fafournoux P, Pouyssegur J. Growth factor activation and
`H+-sensing' of the
Na+/H+
exchanger isoform 1 (NHE1). J Biol Chem. 1994;269:5583-5588.
32.
Bertrand B, Wakabayashi S, Ikeda T, Pouyssegur J,
Shigekawa M. The Na+/H+ exchanger
isoform 1 (NHE1) is a novel member of the
calmodulin-binding proteins: identification and
characterization of calmodulin-binding sites.
J Biol Chem. 1994;269:13703-13709.
This article has been cited by other articles:
 |
|
 |
|
  E. Beem, L. S. Holliday, and M. S. Segal The 1.4-MDa apoptosome is a critical intermediate in apoptosome maturation Am J Physiol Cell Physiol, September 1, 2004; 287(3): C664 - C672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Karmazyn, X. T. Gan, R. A Humphreys, H. Yoshida, and K. Kusumoto The Myocardial Na+-H+ Exchange : Structure, Regulation, and Its Role in Heart Disease Circ. Res., October 29, 1999; 85(9): 777 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Orlov, N. C. Adragna, V. A. Adarichev, and P. Hamet Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension Am J Physiol Cell Physiol, March 1, 1999; 276(3): C511 - C536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Frohlich and M. Karmazyn The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease Cardiovasc Res, November 1, 1997; 36(2): 138 - 148. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||